Literature DB >> 21540827

An optic nerve crush injury murine model to study retinal ganglion cell survival.

Zhongshu Tang1, Shuihua Zhang, Chunsik Lee, Anil Kumar, Pachiappan Arjunan, Yang Li, Fan Zhang, Xuri Li.   

Abstract

Injury to the optic nerve can lead to axonal degeneration, followed by a gradual death of retinal ganglion cells (RGCs), which results in irreversible vision loss. Examples of such diseases in human include traumatic optic neuropathy and optic nerve degeneration in glaucoma. It is characterized by typical changes in the optic nerve head, progressive optic nerve degeneration, and loss of retinal ganglion cells, if uncontrolled, leading to vision loss and blindness. The optic nerve crush (ONC) injury mouse model is an important experimental disease model for traumatic optic neuropathy, glaucoma, etc. In this model, the crush injury to the optic nerve leads to gradual retinal ganglion cells apoptosis. This disease model can be used to study the general processes and mechanisms of neuronal death and survival, which is essential for the development of therapeutic measures. In addition, pharmacological and molecular approaches can be used in this model to identify and test potential therapeutic reagents to treat different types of optic neuropathy. Here, we provide a step by step demonstration of (I) Baseline retrograde labeling of retinal ganglion cells (RGCs) at day 1, (II) Optic nerve crush injury at day 4, (III) Harvest the retinae and analyze RGC survival at day 11, and (IV) Representative result.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21540827      PMCID: PMC3169247          DOI: 10.3791/2685

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  6 in total

1.  RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection.

Authors:  H Levkovitch-Verbin; C Harris-Cerruti; Y Groner; L A Wheeler; M Schwartz; E Yoles
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-12       Impact factor: 4.799

2.  Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies.

Authors:  J Fisher; H Levkovitch-Verbin; H Schori; E Yoles; O Butovsky; J F Kaye; A Ben-Nun; M Schwartz
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

3.  Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation.

Authors:  Zhongshu Tang; Pachiappan Arjunan; Chunsik Lee; Yang Li; Anil Kumar; Xu Hou; Bin Wang; Piotr Wardega; Fan Zhang; Lijin Dong; Yongqing Zhang; Shi-Zhuang Zhang; Hao Ding; Robert N Fariss; Kevin G Becker; Johan Lennartsson; Nobuo Nagai; Yihai Cao; Xuri Li
Journal:  J Exp Med       Date:  2010-03-15       Impact factor: 14.307

4.  GM1 reduces injury-induced metabolic deficits and degeneration in the rat optic nerve.

Authors:  E Yoles; M Zalish; V Lavie; R Duvdevani; S Ben-Bassat; M Schwartz
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-12       Impact factor: 4.799

5.  VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats.

Authors:  Yang Li; Fan Zhang; Nobuo Nagai; Zhongshu Tang; Shuihua Zhang; Pierre Scotney; Johan Lennartsson; Chaoyong Zhu; Yi Qu; Changge Fang; Jianyuan Hua; Osamu Matsuo; Guo-Hua Fong; Hao Ding; Yihai Cao; Kevin G Becker; Andrew Nash; Carl-Henrik Heldin; Xuri Li
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

6.  In vivo-like organotypic murine retinal wholemount culture.

Authors:  Sebastian Gustmann; Nicole Dünker
Journal:  J Vis Exp       Date:  2010-01-11       Impact factor: 1.355

  6 in total
  18 in total

1.  Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury.

Authors:  Kevin A Guttenplan; Benjamin K Stafford; Rana N El-Danaf; Drew I Adler; Alexandra E Münch; Maya K Weigel; Andrew D Huberman; Shane A Liddelow
Journal:  Cell Rep       Date:  2020-06-23       Impact factor: 9.423

2.  Macroglia-microglia interactions via TSPO signaling regulates microglial activation in the mouse retina.

Authors:  Minhua Wang; Xu Wang; Lian Zhao; Wenxin Ma; Ignacio R Rodriguez; Robert N Fariss; Wai T Wong
Journal:  J Neurosci       Date:  2014-03-05       Impact factor: 6.167

3.  Visual impairment in an optineurin mouse model of primary open-angle glaucoma.

Authors:  Henry C Tseng; Thorfinn T Riday; Celia McKee; Catherine E Braine; Howard Bomze; Ian Barak; Carrie Marean-Reardon; Simon W M John; Benjamin D Philpot; Michael D Ehlers
Journal:  Neurobiol Aging       Date:  2015-02-27       Impact factor: 4.673

4.  Optic Nerve Crush in Mice to Study Retinal Ganglion Cell Survival and Regeneration.

Authors:  Evan G Cameron; Xin Xia; Joana Galvao; Masoumeh Ashouri; Michael S Kapiloff; Jeffrey L Goldberg
Journal:  Bio Protoc       Date:  2020-03-20

Review 5.  The role of peroxisome proliferator-activated receptors in healthy and diseased eyes.

Authors:  Paulina Escandon; Brenda Vasini; Amy E Whelchel; Sarah E Nicholas; H Greg Matlock; Jian-Xing Ma; Dimitrios Karamichos
Journal:  Exp Eye Res       Date:  2021-05-16       Impact factor: 3.770

6.  Erythropoietin upregulates growth associated protein-43 expression and promotes retinal ganglion cell axonal regeneration in vivo after optic nerve crush.

Authors:  Haibo Tan; Xin Kang; Yisheng Zhong; Xi Shen; Yu Cheng; Qin Jiao; Lianfu Deng
Journal:  Neural Regen Res       Date:  2012-02-05       Impact factor: 5.135

7.  The therapeutic effects of bone marrow mesenchymal stem cells after optic nerve damage in the adult rat.

Authors:  HaiBo Tan; Xin Kang; ShiHeng Lu; Lin Liu
Journal:  Clin Interv Aging       Date:  2015-02-16       Impact factor: 4.458

8.  Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway.

Authors:  Liwei Zhang; Jiazhou Xu; Ran Liu; Wei Chen; Qishan Chen; Wenjie Hu; Lan Zhou; Ruting Zhang; Hongping Xu; Dongyue Lin; Xuri Li; Zhongshu Tang
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

9.  Retinal ganglion cell ablation in guinea pigs.

Authors:  Ashutosh Jnawali; Xiao Lin; Nimesh B Patel; Laura J Frishman; Lisa A Ostrin
Journal:  Exp Eye Res       Date:  2020-10-27       Impact factor: 3.467

10.  Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage.

Authors:  Xian Zhang; Nan Zhang; Micah A Chrenek; Preston E Girardot; Jiaxing Wang; Jana T Sellers; Eldon E Geisert; Charles Brenner; John M Nickerson; Jeffrey H Boatright; Ying Li
Journal:  Pharmaceutics       Date:  2021-06-16       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.